conivaptan has been researched along with Electrolytes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ezure, Y; Fukaya, AY; Hasegaw, H; Koike, K; Kurasawa, T; Matsukawa, H; Naito, A; Naito, K; Oguma, T; Ohtake, Y; Shigenobu, K; Tanaka, H; Tsuriya, Y | 1 |
| Chanoine, F; Ghali, JK; Ghazzi, M; Hendrix, GH; Konstam, MA; Painchaud, CA; Pressler, ML; Selaru, P; Smith, WB; Thomas, I; Udelson, JE | 1 |
1 trial(s) available for conivaptan and Electrolytes
| Article | Year |
|---|---|
Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Double-Blind Method; Electrolytes; Female; Heart Failure; Hemodynamics; Humans; Kidney; Kinetics; Male; Middle Aged; Osmolar Concentration; Pulmonary Wedge Pressure; Urine | 2001 |
1 other study(ies) available for conivaptan and Electrolytes
| Article | Year |
|---|---|
Pharmacological profile of VP-343, a novel selective vasopressin V2 receptor antagonist, in rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Diuretics; Electrolytes; Female; Furosemide; Male; Mice; Mice, Inbred ICR; Pyrroles; Quinoxalines; Rats; Rats, Brattleboro; Rats, Sprague-Dawley; Receptors, Vasopressin; Urodynamics | 2000 |